339 related articles for article (PubMed ID: 23943020)
21. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.
Duan X; Shang X; Tang P; Jiang H; Yu Z
ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799
[TBL] [Abstract][Full Text] [Related]
22. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up.
Hosoda K; Yamashita K; Moriya H; Mieno H; Watanabe M
World J Gastroenterol; 2017 Apr; 23(15):2723-2730. PubMed ID: 28487609
[TBL] [Abstract][Full Text] [Related]
23. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
24. Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.
Cai MZ; Lv CB; Cai LS; Chen QX
Medicine (Baltimore); 2019 Dec; 98(51):e18451. PubMed ID: 31861019
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of outcomes after surgery between adenocarcinoma of the esophagogastric junction and lower thoracic esophageal squamous cell cancer].
Fu SJ; Fang WT; Mao T; Feng J; Gu ZT; Chen WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):893-6. PubMed ID: 22990917
[TBL] [Abstract][Full Text] [Related]
26. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
28. [Optimal surgical approach for esophagogastric junction carcinoma].
Yamashita H; Seto Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics of lymphatic metastasis and surgical approach of adenocarcinoma of the esophagogastric junction].
Xiao WG; Ma K; Peng L; Li Q; Chen LH; Han YT
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):897-900. PubMed ID: 22990918
[TBL] [Abstract][Full Text] [Related]
30. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
[TBL] [Abstract][Full Text] [Related]
31. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
32. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
[TBL] [Abstract][Full Text] [Related]
34. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T
Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703
[TBL] [Abstract][Full Text] [Related]
35. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
[TBL] [Abstract][Full Text] [Related]
36. Significance of lymph nodal metastases in treatment of esophagogastric adenocarcinoma.
Aikou T; Shimazu H; Takao T; Baba M; Natsugoe S; Simada M
Lymphology; 1992 Mar; 25(1):31-6. PubMed ID: 1569781
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
38. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
Chen XD; He FQ; Chen M; Zhao FZ
Surg Oncol; 2020 Dec; 35():62-70. PubMed ID: 32835903
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
[TBL] [Abstract][Full Text] [Related]
40. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
